Originator Organization Tizona Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization Tizona Therapeutics, Inc.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | Tizona Therapeutics, Inc.Startup | 09 Sep 2020 |